"Unsere Klinik für Lungen- und Bronchialheilkunde in Solingen verfügt über 130 Betten. Das Spektrum der Tätigkeiten umfasst sämtliche Bereiche der Pneumologie mit besonderem Schwerpunkt in den Bereichen Schlaf- und Beatmungsmedizin, thorakale Onkologie, obstruktive und interstitielle Lungenerkrankungen sowie Tuberkulose. Das zertifizierte Weaningzentrum verfügt über eine Intensivstation mit 24 Betten, eine Intermediate Care Station mit acht Betten und eine Dyspnoe-Unit mit Modellcharakter in Deutschland für akute und lebensbedrohliche pneumologische Erkrankungen. Im Schlaflabor stehen zwölf Messplätze zur Verfügung. Wir sind Akademisches Lehrkrankenhaus der Universität zu Köln und gehören zu Diakonie Bethanien (diakonie-bethanien.de)."

During the past decade, Krankenhaus Bethanien gGmbH conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Bethanien gGmbH" #1 sponsor was "Wissenschaftliches Institut Bethanien e.V" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Alung Technologies" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Bethanien gGmbH" #1 collaborator was "CAPNETZ Stiftung" with 1 trials as a collaborator, "Deutsche Luft und Raumfahrt" with 1 trials as a collaborator, "Hannover Medical School" with 1 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 1 trials as a collaborator and "Löwenstein Medical Technology GmbH & Co. KG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Bethanien gGmbH" are "Idiopathic Pulmonary Fibrosis" (5 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (2 trials), "COVID-19" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Dyspnea" (1 trials). Many other conditions were trialed in "Krankenhaus Bethanien gGmbH" in a lesser frequency.

Most popular intervention types in "Krankenhaus Bethanien gGmbH" are "Drug" (7 trials), "Device" (6 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 1015550" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "6 months CPAP" (1 trials) and "Hemolung Respiratory Assist System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Bethanien gGmbH" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus Bethanien gGmbH". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Krankenhaus Bethanien gGmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Bethanien gGmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

Krankenhaus Bethanien gGmbH has several departments that took part in Clinical trials: "Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V." - 18 trials